Clinical Trials Logo

Clinical Trial Summary

The study performs head-to-head comparison of two TAVI-valves: Sapien and Myval.


Clinical Trial Description

The purpose of the present study is to ensure a continuous comparison of the TAVI-valves implanted, and to monitor long-term valve performances. Purpose: To randomize between two TAVI-valve types in patients who according to a heart team conference is found eligible for treatment with more than one valve. Hypotheses: 1. There is no difference in the combined endpoint (death, stroke, moderate/severe para-valvular leakage, moderate/severe device stenosis) between the two valves to be compared. 2. There is no difference between valves in secondary endpoints: death, stroke, moderate/major paravalvular leakage, moderate/severe aortic device stenosis, new pacemaker implantation, readmission for congestive heart failure, 6-minute walk test, and degeneration of the valve as evaluated by computerized tomography (HCT), transthoracic echocardiography (TTE), transesophageal echocardiography (TEE), or MRI. Design: Randomized controlled trial with clinical national registry follow-up. Centers eligible for inclusion: Scandinavian and European centers who fulfill the above mentioned criteria. Randomization: Before randomizing patients, the center decides which two valves the patient is found eligible for, and enters these valves in the electronic randomization form (TrialPartner). Randomization is then performed between these two valves. A patient is only randomized if a dedicated technical TAVI conference has found the patient eligible for treatment with both valves. Consecutive cohorts are established. In the current study we plan to initiate the following cohorts: Cohort B: Patients randomized to the Sapien or the Myval TAVI valve. Operator requirements: Any procedure requires that the physician has performed at least 15 implantations with the valve in use. Otherwise the procedure is performed according to the routine of the institution. ;


Study Design


Related Conditions & MeSH terms

  • Transcatheter Aortic Valve Implantation

NCT number NCT04443023
Study type Interventional
Source Aarhus University Hospital Skejby
Contact
Status Active, not recruiting
Phase N/A
Start date June 15, 2020
Completion date November 2, 2034

See also
  Status Clinical Trial Phase
Recruiting NCT05808907 - Patient Reported Outcomes (PROMs) in Transcatheter Aortic Valve Implantation (TAVI) Patients
Recruiting NCT05133843 - Complete Functional Assessment of Intermediate Coronary Artery Stenosis Before and After Transcatheter Aortic Valve Implantation (TAVI) in Patients With Severe Symptomatic Aortic Valve Stenosis N/A
Completed NCT02976792 - Effectiveness of the NephroCheck™ After TAVI
Enrolling by invitation NCT06212050 - Feasibility, Safety, and Effectiveness of the ACURATE neo2 Transcatheter Heart Valve for Severe Bicuspid Aortic Stenosis
Completed NCT04482816 - Physiological vs Right Ventricular Pacing in Patients With Normal Ventricular Function Post-TAVI N/A
Not yet recruiting NCT05528211 - Safety and Efficacy of Emergent TAVI in Patients With Severe AS
Recruiting NCT06197503 - Randomized Study of Physiological vs Right Ventricular Pacing in Patients With Normal Ventricular Function Post TAVI N/A
Recruiting NCT05804903 - Investigation of the NVT ALLEGRA Plus THV System in Patients With Severe Aortic Stenosis or Failed Surgical Aortic Bioprosthesis N/A
Recruiting NCT03291925 - Primary Non-invasive Cardiac Computed Tomography Versus Routine Invasive Angiography Prior to TAVI N/A
Recruiting NCT05217888 - The Sentinel Registry
Recruiting NCT05491070 - Comparison of Different Vascular Closure Device in TAVI N/A
Recruiting NCT06189976 - Rapid Atrial Pacing After TAVI to Predict Pacemaker Implantation N/A
Completed NCT04921475 - Renal Regional Oxygen Saturation During Transcatheter Aortic Valve Implantation
Completed NCT03966417 - Exercise Training After Transcatheter Aortic Valve Implantation N/A
Not yet recruiting NCT05895097 - Conventional Versus Left Bundle Branch Pacing in TAVI N/A
Not yet recruiting NCT05422170 - HEParin Antagonisation in Transcatheter Aortic Valve Implantation
Completed NCT01539746 - Transcatheter Aortic Valve Implantation Without Predilation N/A
Active, not recruiting NCT05478161 - Investigation of the ALLEGRA THV System With a New Delivery System in Patients With Aortic Stenosis or Failed Surgical Bioprosthesis N/A
Recruiting NCT02659137 - HV Electrophysiology Study In Transcatheter Aortic Valve Implantation Patients N/A
Completed NCT02224066 - Platelet Reactivity After TAVI: A Multicenter Pilot Study Phase 4